Enteral Feeding Devices Market Summary:

The global Enteral Feeding Devices Market Size size was valued at USD 2.85 billion in 2024 and is projected to reach USD 4.93 billion by 2031, growing at a CAGR of 7.13% from 2024 to 2031.

Top 10 Key Companies in Enteral Feeding Devices Market:

Braun SE, Abbott, Boston Scientific Corporation, Conmed Corporation, Becton, Dickinson and Company (BD), Cardinal Health Inc., Avanos Medical, Inc., Neomed, Cook Medical, Baxter

Explore More @ https://www.kingsresearch.com/enteral-feeding-devices-market-682

Enteral Feeding Devices Market Growth Factors:

Increasing Prevalence of Chronic Diseases: The rising incidence of chronic diseases such as cancer, neurological disorders, and gastrointestinal conditions contributes to the growing demand for enteral feeding devices. Patients with these conditions often experience difficulty swallowing or require nutritional support, fuelling market growth.

Aging Population: As the global population continues to age, there is a higher prevalence of age-related conditions such as dysphagia, dementia, and stroke. Older adults are more likely to require enteral nutrition support, driving the demand for enteral feeding devices.

Technological Advancements: Ongoing advancements in enteral feeding device technology improve safety, efficiency, and patient comfort. Innovations such as portable pumps, wireless monitoring systems, and tube placement verification devices enhance the overall patient experience and drive market growth.

Preference for Home Healthcare: enteral feeding devices are used to provide nutrition support outside of traditional hospital settings There is a growing trend towards home-based healthcare and outpatient settings, where

Market Dynamics:

The worldwide Enteral Feeding Devices market size is expected to increase significantly over the forecast period. This increase is due to increased demand for sustainable products in the pharmaceutical and food industries. Rising worries over the usage of synthetic wax have prompted corporations to use natural alternatives in product composition.

Key Developments

• In November 2022, Amsino Medical Group Company received FDA authorization for their AMSafe NeuFlo™ Needleless Connector. This connector is intended to function as a single-use, non-pyrogenic, sterile device.
• It allows for needleless access to intravascular administration systems, making it easier to administer fluids to patients via a cannula inserted into a vein or an artery. Notably, this device protects patients from dangerous infections because it is intended for single-use and cannot be reused.

Enquire Now @ https://www.kingsresearch.com/enquiry/enteral-feeding-devices-market-682